Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Tyrosinemias MeSH Descriptor Data 2025


MeSH Heading
Tyrosinemias
Tree Number(s)
C10.228.140.163.100.875
C16.320.565.100.880
C16.320.565.189.875
C18.452.132.100.875
C18.452.648.100.880
C18.452.648.189.875
Unique ID
D020176
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D020176
Annotation
note X refs: consider also TYROSINE TRANSAMINASE /‌defic or other enzymes /‌defic
Scope Note
A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)
Entry Term(s)
4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease
4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease
4-Hydroxyphenylpyruvate Dioxygenase Deficiency
4-Hydroxyphenylpyruvic Acid Oxidase Deficiency
Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase
Deficiency Disease, Fumarylacetoacetase
Deficiency Disease, Tyrosine Transaminase
Fumarylacetoacetase Deficiency
Fumarylacetoacetase Deficiency Disease
Hepatorenal Tyrosinemia
Hereditary Tyrosinemia, Type I
Hereditary Tyrosinemia, Type II
Hereditary Tyrosinemia, Type III
Hereditary Tyrosinemias
Hypertyrosinemia
Hypertyrosinemia, Type I
Keratosis Palmoplantaris with Corneal Dystrophy
Oregon Type Tyrosinemia
Richner-Hanhart Syndrome
Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type
Tat Deficiency
Tyrosine Aminotransferase Deficiency
Tyrosine Transaminase Deficiency
Tyrosine Transaminase Deficiency Disease
Tyrosinemia
Tyrosinemia Type 1
Tyrosinemia, Type 2
Tyrosinemia, Type I
Tyrosinemia, Type II
Tyrosinemia, Type III
Tyrosinemias, Hereditary
Tyrosinosis, Oculocutaneous Type
NLM Classification #
QU 265.5.A5
Previous Indexing
Amino Acid Metabolism, Inborn Errors (1967-1999)
Public MeSH Note
2000
History Note
2000
Date Established
2000/01/01
Date of Entry
1999/11/04
Revision Date
2016/06/28
Tyrosinemias Preferred
Tyrosinemia, Type I Narrower
Tyrosinemia, Type II Narrower
Tyrosinemia, Type III Narrower
page delivered in 0.135s